Table 2 The characteristics and distributions of the total cost attributable to CRBSI
Variables | n | Median($) | P | |
|---|---|---|---|---|
Age(yr.) | ≤ 59 | 33 | 2977.9 | 0.152 |
> 60 | 48 | 4424.3 | ||
Sex | Male | 50 | 3070.5 | 0.290 |
Female | 31 | 4042.8 | ||
Occupation | Worker | 7 | 1902.5 | 0.702 |
Farmer | 17 | 2977.9 | ||
Office clerk | 9 | 3528.6 | ||
Retiree | 30 | 4436.9 | ||
Others | 18 | 3495.1 | ||
Immunosuppressive drug history | No | 69 | 3458.8 | 0.481 |
Yes | 12 | 5316.0 | ||
ICU | No | 65 | 2420.7 | < 0.001 |
Yes | 16 | 9154.3 | ||
Principal diagnosis | Cancer | 59 | 3087.0 | 0.218 |
Inflammation | 6 | 8760.0 | ||
Others | 16 | 4368.9 | ||
Other diagnoses | No | 28 | 1930.6 | 0.053 |
Yes | 53 | 4042.8 | ||
Operation level | ≤ 2 | 24 | 2920.2 | 0.228 |
3 | 24 | 6002.2 | ||
4 | 33 | 3087.0 | ||
Catheter number | ≤ 5 | 64 | 2549.0 | 0.002 |
6 | 17 | 7587.4 | ||
Pathogenic microorganism | G- | 25 | 2335.6 | 0.137 |
G+ | 42 | 3601.9 | ||
Fungus | 14 | 6340.1 |